Clinical Implications of Triple Combination Therapies(Metformin+Alpha-glucosidase Inhibitor+DPP-4 Inhibitor) in Type 2 Diabetes
Not Applicable
- Conditions
- Type 2 Diabetes mellitus
- Registration Number
- JPRN-UMIN000010061
- Lead Sponsor
- SANWA KAGAKU KENKYUSHO CO.,LTD
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 45
Inclusion Criteria
Not provided
Exclusion Criteria
1.Patients require insulin or oral antidiabetic drug therapy other than metformin and/or miglitol 2.Female patients who were pregnant,suspected of being pregnant,planning a pregnancy,or lactating 3.Patients with,or a history of,serious renal disease(Serum Creatinine of >=2mg/dL 4.Any patients deemed by the investigator to be ineligible for participation in this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method